BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35945111)

  • 1. Clinical and histopathological features of bladder cancer following radiotherapy for prostate cancer: A comparative study.
    Scherñuk J; González MI; Vecchio F; Alfieri AG; Tobia IP; Tejerizo JC; Favre GA
    Urol Oncol; 2022 Nov; 40(11):492.e1-492.e6. PubMed ID: 35945111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radical cystectomy in bladder cancer patients previously treated for prostate cancer: Insights from a large European multicentric series.
    Tappero S; Chierigo F; Parodi S; Bandini M; Moschini M; Cucchiara V; Chessa F; Di Maida F; Mari A; Manfredi M; Mantica G; Cerruto MA; Fiori C; Schiavina R; Briganti A; Suardi N; Brunocilla E; Antonelli A; Porpiglia F; Minervini A; Montorsi F; Terrone C
    Surg Oncol; 2023 Oct; 50():101973. PubMed ID: 37454433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
    Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF
    Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancer.
    Sandhu JS; Vickers AJ; Bochner B; Donat SM; Herr HW; Dalbagni G
    BJU Int; 2006 Jul; 98(1):59-62. PubMed ID: 16626308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer.
    Yee DS; Shariat SF; Lowrance WT; Sterbis JR; Vora KC; Bochner BH; Donat SM; Herr HW; Dalbagni G; Sandhu JS
    J Urol; 2010 May; 183(5):1751-6. PubMed ID: 20299035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant Gleason Score ≥ 7 prostate cancer is an independent prognosticator for poor survival in nonmetastatic bladder cancer patients undergoing radical cystoprostatectomy.
    Thomas C; Giesswein A; Hainz M; Stein R; Rubenwolf P; Roos FC; Neisius A; Nestler S; Hampel C; Jäger W; Wiesner C; Thüroff JW
    Int Urol Nephrol; 2015 Nov; 47(11):1789-96. PubMed ID: 26377495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical Cystectomy for Bladder Cancer in Patients With and Without a History of Pelvic Irradiation: Survival Outcomes and Diversion-related Complications.
    Nguyen DP; Al Hussein Al Awamlh B; Faltas BM; O'Malley P; Ayangbesan A; Inoyatov IM; Scherr DS
    Urology; 2015 Jul; 86(1):99-106. PubMed ID: 26142590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic Features of Muscle-invasive Bladder Cancer Arising After Prostate Radiotherapy.
    Mossanen M; Carvalho FLF; Muralidhar V; Preston MA; Reardon B; Conway JR; Curran C; Freeman D; Sha S; Sonpavde G; Hirsch M; Kibel AS; Van Allen EM; Mouw KW
    Eur Urol; 2022 May; 81(5):466-473. PubMed ID: 34953602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome predictors of radical cystectomy in patients with cT4 prostate cancer: a multi-institutional study of 62 patients.
    Spahn M; Morlacco A; Boxler S; Joniau S; Briganti A; Montorsi F; Gontero P; Bader P; Frohneberg D; van Poppel H; Karnes RJ;
    BJU Int; 2017 Nov; 120(5B):E52-E58. PubMed ID: 28220605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical Cystectomy in Pathological T4a and T4b Bladder Cancer Patients: Is There Any Space for Sub Stratification?
    Moschini M; Zamboni S; Mattei A; Baumeister P; Di Bona C; Cornelius J; Shariat SF; Freschi M; Zaffuto E; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A;
    Urol Int; 2019; 102(3):269-276. PubMed ID: 30695782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experience.
    Moschini M; Karnes RJ; Sharma V; Gandaglia G; Fossati N; Dell'Oglio P; Cucchiara V; Capogrosso P; Shariat SF; Damiano R; Salonia A; Montorsi F; Briganti A; Gallina A; Colombo R
    Eur J Surg Oncol; 2016 May; 42(5):735-43. PubMed ID: 26927300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased BCL2L12 expression predicts the short-term relapse of patients with TaT1 bladder cancer following transurethral resection of bladder tumors.
    Foutadakis S; Avgeris M; Tokas T; Stravodimos K; Scorilas A
    Urol Oncol; 2014 Jan; 32(1):39.e29-36. PubMed ID: 23790536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does muscle invasive bladder cancer following pelvic radiotherapy portend worse prognosis? A seer-based study.
    Natale C; Leinwand G; Zeineddine F; Silberstein JL; Krane LS
    Cancer Treat Res Commun; 2020; 24():100177. PubMed ID: 32454387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes.
    Bochner BH; Dalbagni G; Marzouk KH; Sjoberg DD; Lee J; Donat SM; Coleman JA; Vickers A; Herr HW; Laudone VP
    Eur Urol; 2018 Oct; 74(4):465-471. PubMed ID: 29784190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative outcomes of primary, recurrent, and progressive high-risk non-muscle-invasive bladder cancer.
    Thomas F; Noon AP; Rubin N; Goepel JR; Catto JW
    Eur Urol; 2013 Jan; 63(1):145-54. PubMed ID: 22985746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy.
    Martini A; Afferi L; Zamboni S; Schultz JG; Lonati C; Mattei A; Karnes RJ; Soligo M; Stabile A; Di Trapani E; De Cobelli O; Simone G; Simeone C; Alvarez-Maestro M; Gandaglia G; Gallina A; Colombo R; Briganti A; Montorsi F; Xylinas E; Shariat SF; Moschini M
    J Urol; 2021 Oct; 206(4):885-893. PubMed ID: 34032498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of persistent prostate cancer after radiotherapy detected at radical cystoprostatectomy for bladder cancer.
    Meeks JJ; Kern SQ; Dalbagni G; Eastham JA; Sandhu JS
    J Urol; 2014 Jun; 191(6):1760-3. PubMed ID: 24373801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience.
    Efstathiou JA; Spiegel DY; Shipley WU; Heney NM; Kaufman DS; Niemierko A; Coen JJ; Skowronski RY; Paly JJ; McGovern FJ; Zietman AL
    Eur Urol; 2012 Apr; 61(4):705-11. PubMed ID: 22101114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of prostate cancer radiotherapy on the biological behavior and specific mortality of subsequent bladder cancer.
    Guo X; Liu M; Hou H; Liu S; Zhang X; Zhang Y; Wu P; Pang C; Wang J
    Int J Clin Oncol; 2019 Aug; 24(8):957-965. PubMed ID: 30903422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
    Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
    J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.